Navigation Links
New Data on Patient-Reported Improvements in Quality of Life Measures and Other Clinical Responses in Moderate to Severe Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol) Highlighted at American College of Rheumatology Meeting
Date:11/7/2011

coses are endemic.

Malignancies

During controlled and open-labeled portions of CIMZIA studies of Crohn's disease and other diseases, malignancies (excluding non-melanoma skin cancer) were observed at a rate of 0.5 per 100 patient-years among 4,650 CIMZIA-treated patients versus a rate of 0.6 per 100 patient-years among 1,319 placebo-treated patients. In studies of CIMZIA for Crohn's disease and other investigational uses, there was one case of lymphoma among 2,657 CIMZIA-treated patients and one case of Hodgkin lymphoma among 1,319 placebo-treated patients.  In CIMZIA RA clinical trials (placebo-controlled and open label) a total of three cases of lymphoma were observed among 2,367 patients.  This is approximately 2-fold higher than expected in the general population.  Patients with RA, particularly those with highly active disease, are at a higher risk for the development of lymphoma. The potential role of TNF blocker therapy in the development of malignancies is not known.

Malignancies, some fatal, have been reported among children, adolescents, and young adults who received treatment with TNF-blocking agents (initiation of therapy less than or equal to 18 years of age), of which CIMZIA is a member.  Approximately half of the cases were lymphoma (including Hodgkin's and non-Hodgkin's lymphoma, while the other cases represented a variety of different malignancies and included rare malignancies associated with immunosuppression and malignancies not usually observed in children and adolescents.  Most of the patients were receiving concomitant immunosuppressants.  

Cases of acute and chronic leukemia have been reported with TNF-blocker use.  Even in the absence of TNF-blocker therapy, patients with RA may be at a higher risk (approximately 2-fold) than the general population for developing leukemia.

Heart Failure

Cases of worsening congestive heart failure (CHF) a
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Amylin to Present Data Showing Investigational Metreleptin Treatment Led to Long-Term Improvements in Diabetes and Lipid Control in Patients with Lipodystrophy
2. QNEXA® Phase 3 Data in The Lancet Show Significant Weight Loss and Broad Improvements in Co-Morbidities
3. NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development
4. Reportlinker Adds Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential
5. Terumo Cardiovascular Systems Reaches Agreement on Terms of Consent Decree With FDA Regarding Quality System Improvements
6. Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements
7. Improvements in Recurrence-Free Survival in Early Stages of Colorectal Cancer Will Limit Growth of Drug Treatment Opportunities for Advanced Disease
8. Neupro® (Rotigotine) Provided Clinically Relevant Improvements in Health-Related Quality of Life for People with Parkinsons Disease
9. Ekahau RTLS Enables Improvements in Staff Safety in Austrian Psychiatric Hospital
10. Data Presented at the European Working Group on Gaucher Disease Demonstrate Continuous Improvements in Bone Mineral Density for VPRIV(R) (Velaglucerase Alfa) Through 69 Months
11. Phase 2 Trial of LX4211 Demonstrates Significant and Rapid Improvements in Multiple Parameters in Type 2 Diabetic Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 XRpro ... for drug discovery and development services which features ... the pharmaceutical industry, announced financial results for the ... Timothy C.  Tyson, Chairman of XRpro Sciences commented, ... successfully transition from development stage to commercial stage ...
(Date:3/27/2015)... 27, 2015  Valeant Pharmaceuticals International, Inc. (NYSE: ... its previously announced registered offering of common shares in ... Pursuant to the Offering, the Company issued 7,286,432 common ... aggregate gross proceeds of approximately $1.45 billion. On March ... and Exchange Commission a final prospectus supplement to its ...
(Date:3/27/2015)... NORTH HOLLYWOOD, Calif. , March 27, 2015 /PRNewswire/ ... quality of life of myeloma patients while working toward ... Brian Higgins (D-NY) for introducing a federal resolution ... month of March 2015 as "National Multiple Myeloma Awareness ... people living with myeloma worldwide, and more than 110,000 ...
Breaking Medicine Technology:XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2
... 13, 2011 U.S. Marshals, acting under a court ... on Jan. 5 and 6, seized all dental devices ... (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... an FDA inspection that found significant deficiencies in the ...
... Although 2010 brought healthcare reform, investors are wondering if ... expect some volatility in the sector, as the Republican-led ... through a repeal effort or withholding funding for portions ... Poor,s Equity Research. "Healthcare reform or ...
Cached Medicine Technology:U.S. Marshals Seize Dental Devices From Florida Manufacturer 2S&P Equity Research Issues Health Care Sector Predictions for 2011 2S&P Equity Research Issues Health Care Sector Predictions for 2011 3S&P Equity Research Issues Health Care Sector Predictions for 2011 4S&P Equity Research Issues Health Care Sector Predictions for 2011 5S&P Equity Research Issues Health Care Sector Predictions for 2011 6
(Date:3/27/2015)... (PRWEB) March 27, 2015 First Choice ... today. The new facility is located 12665 W Lake Houston ... a resident of Summerwood, I look forward to delivering the ... Dr. Sowell, Facility Medical Director of First Choice Emergency Room ... Emergency Room made a donation to Summer Creek High School ...
(Date:3/27/2015)... NY (PRWEB) March 27, 2015 Ticket Down is ... Concert in 2015. After a phenomenal and highly successful ... "Nashville" will be going out on tour again in 2015 and ... tour gets underway on April 29th in New York City at ... at the Comerica Theatre on May 10th. , Fans of the ...
(Date:3/27/2015)... PA and LONDON, UK (PRWEB) March 27, 2015 ... of DrugDev SiteStart Melissa (Liss) Easy was named to ... , The 40 Under 40 list spotlights 40 dynamic, ... their professional accomplishments and community involvement. Winners are honored ... a special supplement of the Philadelphia Business Journal. , ...
(Date:3/27/2015)... FL and London, UK (PRWEB) March 27, 2015 ... announced today that it has appointed Sean Fitzgerald, a ... role of Chief Operating Officer and Interim Chief Financial ... President of leading education technology innovator, EverFi, backed by ... Schmidt, and Twitter founder Evan Williams. Prior to EverFi, ...
(Date:3/27/2015)... 27, 2015 Operatic contenders and their ... on April 17th. The universally acclaimed baritone Sherrill Milnes ... annual Opera Idol at The Merion in Evanston. The ... has drawn aspiring opera singers from around the country. ... of the finest young talent in the country,” said ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Opens New Facility in Houston, Texas 2Health News:Nashville Live in Concert Tickets in New York, Boston, Washington, DC, Chicago, Minneapolis, San Francisco, Los Angeles and Phoenix Now On Sale at TicketDown.com 2Health News:DrugDev Founder Melissa Easy is 2015 Philadelphia Business Journal 40 Under 40 Honoree 2Health News:GenSight Appoints Former Technology Executive as Chief Operating Officer 2Health News:Opera Idol Competition At The Merion In Evanston 2
... of illicit drugs, but have got enchanted with prescription ... ,The MTF survey has been the concerted effort of ... most recent survey, collating information from 48,460 students from ... and 12th grades has revealed that marijuana use had ...
... over stressful conditions provide immunity// to face stressors which ... ,Scientists from National Institute of Mental Health (NIMH) ... inoculates against such hard knocks - the circuitry of ... executive hub, the prefrontal cortex, but also altered it ...
... in this week's PLoS Medicine suggest possible new avenues ... paper, researchers led by Dominique Mazier from the Laboratory ... novel compound, tazopsine, from a plant traditionally used against ... against the liver stages of human and mouse malaria. ...
... A variant gene has been identified by researchers that help ... gene seems to confer a preserving effect upon the mental ... from the Albert Einstein College of Medicine of Yeshiva University. ... ,Dr. Nir Barzilai, the lead researcher is the director of ...
... heart surgery years ago underwent the same procedure that ... is raring to get back to work after recuperating from ... vessel called aorta, in his heart ,that was torn. ... procedure for a condition called dissecting aortic aneurysm.As a young ...
... is a mint flavored sweetener, produced naturally by plants and ... an ingredient in chewing gum, toothpaste, mouthwash and other products. ... Service (ARS) and collaborators have developed a genetically engineered bacteria, ... used to produce Xylitol on a large scale. ...
Cached Medicine News:Health News:Prior Experience to Stress Acts as an Immunization 2Health News:You may Live Long and Think Clear With a Variant Gene 2Health News:Pioneer Heart Surgeon Faced the Scalpel at 98 2Health News:Xylitol To Be Produced By Genetically Engineered E. Coli 2
Shielding's new Surgical Drop Away / Flex Back Apron offers top of the shoulder velcro flaps for an adjustable fit. Features elastic back panels for added comfort and support. For quick removal apron...
Shielding's Standard Coat Apron with open back allows for freedom of movement, maximum flexibility and increased comfort....
This set includes 2 small, 1 medium, 1 large gonad shields and a belt. The shields and belt is an interchangeable system attached by velcro....
Lap pad used to protect pelvic regions...
Medicine Products: